We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,122 hedge funds and large institutions have $60B invested in Biogen in 2017 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 399 increasing their positions, 384 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

248% more first-time investments, than exits

New positions opened: 167 | Existing positions closed: 48

11% more funds holding

Funds holding: 1,014 → 1,122 (+108)

4% more repeat investments, than reductions

Existing positions increased: 399 | Existing positions reduced: 384

2% more capital invested

Capital invested by funds: $59B → $60B (+$967M)

0.05% less ownership

Funds ownership: 89.15% → 89.1% (-0.05%)

26% less funds holding in top 10

Funds holding in top 10: 38 → 28 (-10)

32% less call options, than puts

Call options by funds: $989M | Put options by funds: $1.44B

Holders
1,122
Holders Change
+108
Holders Change %
+10.65%
% of All Funds
25.45%
Holding in Top 10
28
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-26.32%
% of All Funds
0.64%
New
167
Increased
399
Reduced
384
Closed
48
Calls
$989M
Puts
$1.44B
Net Calls
-$456M
Net Calls Change
-$187M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$623M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$233M
3
PC
PointState Capital
New York
+$158M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$124M
5
JP Morgan Chase
JP Morgan Chase
New York
+$107M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$689M
2
TCIM
TIAA CREF Investment Management
New York
-$232M
3
Citadel Advisors
Citadel Advisors
Florida
-$161M
4
Bank of America
Bank of America
North Carolina
-$156M
5
O
OrbiMed
New York
-$128M
Name Holding Trade Value Shares
Change 		Change in
Stake
QIM
1126
Quantitative Investment Management
Virginia
– -$45.6M -145,500 Closed
Renaissance Technologies
1127
Renaissance Technologies
New York
– -$37.6M -120,161 Closed
GTP
1128
Global Thematic Partners
New York
– -$34M -108,540 Closed
PI
1129
PGGM Investments
Netherlands
– -$32.5M -103,947 Closed
SAM
1130
Sentinel Asset Management
Vermont
– -$22.6M -72,200 Closed
BA
1131
Bridgewater Associates
Connecticut
– -$13.8M -44,198 Closed
Voloridge Investment Management
1132
Voloridge Investment Management
Florida
– -$5.39M -17,217 Closed
BCM
1133
Barometer Capital Management
Ontario, Canada
– -$5.17M -16,500 Closed
SCM
1134
Sio Capital Management
New York
– -$4.87M -15,549 Closed
CM
1135
Crestline Management
Texas
– -$3.49M -11,145 Closed
NLI
1136
Nippon Life Insurance
Japan
– -$2.39M -7,628 Closed
DF
1137
Donoghue Forlines
Massachusetts
– -$2.19M -6,984 Closed
IA
1138
Icon Advisers
Colorado
– -$1.78M -5,700 Closed
DCM
1139
Dynamic Capital Management
Jersey
– -$1.63M -5,218 Closed
FAM
1140
Fortaleza Asset Management
Illinois
– -$824K -2,630 Closed
DCM
1141
Dimension Capital Management
Florida
– -$628K -2,007 Closed
NPC
1142
National Planning Corporation
California
– -$534K -1,704 Closed
WC
1143
Woodstock Corp
Massachusetts
– -$513K -1,637 Closed
AGM
1144
Alpine Global Management
New York
– -$483K -1,541 Closed
LCM
1145
Landscape Capital Management
New Jersey
– -$481K -1,535 Closed
CIA
1146
Capital Investment Advisors
Georgia
– -$385K -1,228 Closed
NFG
1147
Next Financial Group
Texas
– -$343K -1,016 Closed
NAMA
1148
Nikko Asset Management Americas
New York
– -$282K -900 Closed
ICOA
1149
Investment Centers of America
North Dakota
– -$274K -854 Closed
RCA
1150
Rex Capital Advisors
Rhode Island
– -$263K -840 Closed
43 44 45
46
47

BIIB Hedge Fund Activity: Q4 2017 in Review

1,122 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q4 2017, worth a combined $60B — up 1.6% from $59B a quarter earlier.

Buyers outnumbered sellers: 167 funds opened new BIIB positions and 48 closed out — a net gain of 119 holders — while 399 added to existing stakes and 384 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $623M. The largest seller was T. Rowe Price Associates, cutting an estimated $689M.

  • 1,122 institutional investors held Biogen (BIIB) as of Q4 2017, up from 1,014 in Q3 2017.
  • Funds reported $60B of Biogen stock for Q4 2017, up 1.6% quarter-over-quarter.
  • 167 funds opened new Biogen positions in Q4 2017 and 48 closed out, a net change of +119 holders.
  • The largest Biogen buyer in Q4 2017 was Fidelity Investments, an estimated $623M added.
  • The largest Biogen seller in Q4 2017 was T. Rowe Price Associates, an estimated $689M sold.

Based on aggregated 13F filings for Q4 2017.